Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.100
+0.020 (1.85%)
At close: Apr 28, 2026, 4:00 PM EDT
1.100
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $4.15 million as of April 28, 2026. Its market cap has decreased by -18.50% in one year.
Market Cap
4.15M
Enterprise Value
1.34M
1-Year Change
-18.50%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $4.15M, a decrease of -99.64%. That is a compound annual growth rate of -68.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 4.07M | -41.16% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dermata Therapeutics | 4.99M |
| Pulmatrix | 4.93M |
| Revelation Biosciences | 4.35M |
| 60 Degrees Pharmaceuticals | 4.30M |
| VivoSim Labs | 4.23M |
| AIM ImmunoTech | 4.21M |
| Galmed Pharmaceuticals | 4.13M |
| Matinas BioPharma Holdings | 3.91M |